Dr. Mohammad Akrami | Pharmaceutical Biomaterials | Best Researcher Award
Asistant Professor at Tehran University of Medical Sciences, Iran
Summary:
Dr. Mohammad Akrami is an Assistant Professor at the Pharmaceutical Biomaterials Department, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS). He holds a PhD in Pharmaceutical Biomaterials from TUMS, focusing on peptide-functionalized gold nanoparticles for breast cancer therapy, and an M.Sc. in Biological Sciences from Tarbiat Modares University. With a robust background in R&D at SOHA Pharmaceutical Company and extensive expertise in pharmaceutical analytical methods, 3D printing, and nanoparticle drug delivery systems, Dr. Akrami is actively involved in advancing pharmaceutical sciences and education in Iran.
Profile:
Education:
Dr. Mohammad Akrami pursued his academic journey with dedication and focus, culminating in significant achievements in pharmaceutical sciences. He completed his PhD candidacy in Pharmaceutical Biomaterials at the Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS) from 2011 to 2016. His doctoral research centered on the preparation and characterization of peptide-functionalized gold nanoparticles for potential applications in breast cancer cell therapy. Prior to his PhD, Dr. Akrami earned his M.Sc. in Biological Sciences at Tarbiat Modares University in Tehran, Iran, where his thesis explored plasminogen activation mechanisms by plasminogen activators and the role of anti-human plasminogen monoclonal antibodies. His educational path reflects his commitment to advancing biomedical research and pharmaceutical technology.
Professional Experience:
Dr. Mohammad Akrami brings a wealth of experience in pharmaceutical research and development, complemented by his roles in academia and industry. Currently serving as an Assistant Professor at the Pharmaceutical Biomaterials Department, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), he has also been extensively involved in teaching and research. His career includes pivotal roles such as R&D Head, Consultant, and Expert at SOHA Pharmaceutical Company, where he contributed significantly to pharmaceutical analytical method development, solid and semi-solid formulation, and diagnostic biochemical kit development. Dr. Akrami’s leadership extends to his current position as Chairman of the Board at Zist Mavad Pharmed Co. and his involvement in national healthcare initiatives, including his membership in the Ministry of Health’s Productivity Secretariat and educational committees focusing on entrepreneurship and knowledge-based medical businesses. His professional journey underscores his commitment to advancing pharmaceutical sciences and healthcare innovation in Iran.
Research Interest:
Dr. Mohammad Akrami’s research interests span several innovative areas within pharmaceutical sciences and biomedical engineering. He focuses on cutting-edge fields such as 3D pharming and bioprinting, aiming to revolutionize drug delivery and tissue engineering. His work includes the fabrication of nanoghosts and microbubble-based systems for targeted drug delivery, particularly in cancer therapy. Dr. Akrami also explores the physicochemical properties of drugs and their quality control methods, emphasizing advancements in cancer targeting through novel pharmaceutical formulations. His research aims to bridge the gap between theoretical knowledge and practical applications, contributing significantly to the fields of pharmaceutical biomaterials and medical engineering.
Award:
Dr. Mohammad Akrami has been recognized with the “Member of Selected Process” award at the 24th Shahid Motahari Festival, held by Tehran University of Medical Sciences in 2023. This prestigious accolade highlights his exceptional contributions to the field of pharmaceutical sciences and biomedical engineering, reflecting his dedication to research and academic excellence.
Publication:
- Authors: M. Alipour, M. Baneshi, S. Hosseinkhani, R. Mahmoudi, A. Jabari Arabzadeh, …
- Journal: Journal of Biomedical Materials Research Part A
- Year: 2020
- Volume: 108
- Issue: 4
- Pages: 839-850
- Citations: 117
Tuning the anticancer activity of a novel pro-apoptotic peptide using gold nanoparticle platforms
- Authors: M. Akrami, S. Balalaie, S. Hosseinkhani, M. Alipour, F. Salehi, A. Bahador, …
- Journal: Scientific Reports
- Year: 2016
- Volume: 6
- Article number: 31030
- Citations: 86
- Authors: Milad Ghorbania, Bahareh Bigdelib, Leili Jalili-balehc, Hadi Baharifard …
- Journal: European Journal of Pharmaceutical Sciences
- Year: 2017
- Volume: 79
- Authors: MAMA Hassan Bardania, Reza Mahmoudi, Hamed Bagheri, Zeinab Salehpour …
- Journal: Scientific Reports
- Year: 2020
- Volume: 10
- Article number: 6129
- Citations: 78
- Authors: HB Ali mousavizadeh, Ali Jabbari, Mohammad Akrami
- Journal: Colloids and Surfaces B: Biointerfaces
- Year: 2017
- Volume: 73